Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Craig Lawrance

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Gastroenterology and Hepatology|December 24, 2010
Topical agents for idiopathic distal colitis and proctitisIan Craig Lawrance
Expert Opinion on Investigational Drugs|May 23, 2012
Modifying T-cell trafficking to the intestinal as a potential management for inflammatory bowel diseaseIan Craig Lawrance
Journal of Gastroenterology and Hepatology|October 16, 2004
Infliximab in the management of the extra-intestinal manifestations of Crohn's diseaseIan Craig Lawrance
World Journal of Gastrointestinal Pharmacology and Therapeutics|May 18, 2011
Novel topical therapies for distal colitisIan Craig Lawrance
World Journal of Gastroenterology|April 3, 2009
Use of mycophenolate mofetil in inflammatory bowel diseaseTerrence Tan, Ian Craig Lawrance
World Journal of Gastroenterology|September 19, 2009
Stevens-Johnson syndrome complicating adalimumab therapy in Crohn's diseaseMuna Salama, Ian-Craig Lawrance
World Journal of Gastroenterology|April 30, 2008
Use of infliximab in the prevention and delay of colectomy in severe steroid dependant and refractory ulcerative colitisRobert P Willert, Ian Craig Lawrance
Journal of Gastroenterology and Hepatology|April 28, 2006
Poor correlation between clinical impression, the small colonic polyp and their neoplastic riskIan Craig Lawrance, Colin Sherrington, Kevin Murray
Inflammatory Bowel Diseases|September 29, 2005
Proteomics: an overviewIan Craig Lawrance, Borut Klopcic, Valerie C Wasinger
World Journal of Gastroenterology|July 18, 2009
Correlation of MRI-determined small bowel Crohn's disease categories with medical response and surgical pathologyIan Craig Lawrance, Christopher J Welman, Peter Shipman, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Gastroenterology and Hepatology|December 24, 2010
Topical agents for idiopathic distal colitis and proctitisIan Craig Lawrance
Expert Opinion on Investigational Drugs|May 23, 2012
Modifying T-cell trafficking to the intestinal as a potential management for inflammatory bowel diseaseIan Craig Lawrance
Journal of Gastroenterology and Hepatology|October 16, 2004
Infliximab in the management of the extra-intestinal manifestations of Crohn's diseaseIan Craig Lawrance
World Journal of Gastrointestinal Pharmacology and Therapeutics|May 18, 2011
Novel topical therapies for distal colitisIan Craig Lawrance
World Journal of Gastroenterology|April 3, 2009
Use of mycophenolate mofetil in inflammatory bowel diseaseTerrence Tan, Ian Craig Lawrance
World Journal of Gastroenterology|September 19, 2009
Stevens-Johnson syndrome complicating adalimumab therapy in Crohn's diseaseMuna Salama, Ian-Craig Lawrance
World Journal of Gastroenterology|April 30, 2008
Use of infliximab in the prevention and delay of colectomy in severe steroid dependant and refractory ulcerative colitisRobert P Willert, Ian Craig Lawrance
Journal of Gastroenterology and Hepatology|April 28, 2006
Poor correlation between clinical impression, the small colonic polyp and their neoplastic riskIan Craig Lawrance, Colin Sherrington, Kevin Murray
Inflammatory Bowel Diseases|September 29, 2005
Proteomics: an overviewIan Craig Lawrance, Borut Klopcic, Valerie C Wasinger
World Journal of Gastroenterology|July 18, 2009
Correlation of MRI-determined small bowel Crohn's disease categories with medical response and surgical pathologyIan Craig Lawrance, Christopher J Welman, Peter Shipman, et al.
Pageof 2